Helicobacter pylori disease in childhood

Clinical Pediatrics

Volumn 35, Issue 4, 1996, Pages 175-183

  Blecker, Uwe ^a,b  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ARTICLE; ATROPHIC GASTRITIS; BACTERIAL COLONIZATION; GASTRITIS; GENETIC SUSCEPTIBILITY; HELICOBACTER PYLORI; HUMAN; PATHOGENESIS; PEPTIC ULCER; RISK ASSESSMENT; RISK FACTOR; STOMACH CANCER; STOMACH LYMPHOMA;

EID: 0030025797     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992289603500401     Document Type: Article

References (97)

1. Marshall BJ, Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983;1:1273-1275.
2. Editorial. Pyloric Campylobacter finds a volunteer. Lancet. 1985;1:1021-1022.
3. Blecker U, Hauser B, Lanciers S, et al. The prevalence of Helicobacter pylori positive serology in asymptomatic children. J Pediatr Gastroenterol Nutr. 1993;16:252-256.
4. Blaser MJ. Epidemiology of Campylobacter pylori infections. Rev Infect Dis. 1990;12:99-106.
5. Dooley CP, Cohen H. The clinical significance of Campylobacter pylori. Ann Intern Med. 1988;108:70-79.
6. Drumm B. Helicobacter pylori. Arch Dis Child. 1990,65:1278-1282.
7. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ. Attempt to fulfill Koch's postulates for pyloric Campylobacter. Med J Aust. 1985;142:436-439.
8. Czinn SJ, Speck WT. Campylobacter pylori: a new pathogen? J Pediatr. 1989;114.670-672.
9. Veldhuyzen van Zanten S, Sherman P. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer, and non-ulcer dyspepsia: a systematic overview. Can Med Assoc J. 1994;150:177-185.
10. Blaser MJ. Hypothesis on the pathogenesis and natural history of Helicobacter pylori induced inflammation. Gastroenterology. 1992;102:720-727.
11. Drumm B, Sherman P, Cutz E, Karmali M. Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children. N Engl J Med. 1987;316:1557-1561.
12. De Giacomo C, Fiocca R, Villani L, et al. Helicobacter pylori infection and chronic gastritis: clinical, serological and histologic correlations in children treated with amoxicillin and colloidal bismuth subcitrate. J Pediatr Gastroenterol Nutr. 1990;11:310-316.
13. Hassall E, Dimmick JE. Unique features of Helicobacter pylori disease in children. Dig Dis Sci. 1991;36:417-423.
14. Oderda G, Dell'Ollio D, Morra I, Ansaldi N. Campylobacter pylori gastritis: long-term results of treatment with amoxicillin. Arch Dis Child 1989; 64:326-329.
15. Drumm B, Sherman P, Chiasson D, et al. Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin. J Pediatr. 1988;113:908-912.
16. Yeung CK, Fu KH, Yuen KY, et al. Helicobacter pylori and associated duodenal ulcer. Arch Dis Child. 1990,65:1212-1216.
17. Deckelbaum RJ, Roy CC, Lussier-Laviaroff J, Morin CL. Peptic ulcer disease: a clinical study in 73 children Can Med Assoc J. 1974;111:225-228.
18. Drumm B, Rhoads JM, Stringer DA, et al. Peptic ulcer disease in children: etiology, clinical findings, and clinical course. Pediatrics. 1988;82:410-414.
19. Murphy MS, Eastham EJ, Jimenez M, et al. Duodenal ulceration. review of 110 cases. Arch Dis Child. 1987;62:544-558.
20. Puri P, Boyd E, Blake N, Guiney EJ. Duodenal ulcer in childhood: a continuing disease in adult life. J Pediatr Surg. 1978;13.525-526.
21. Drumm B, O'Brien A, Cutz E, Sherman P. Campylobacter pyloridis-associated primary gastritis in children. Pediatrics. 1987;80:192-195.
22. Kilbridge PM, Dahms BB, Czinn SJ. Campylobacter pylori associated gastritis and peptic ulcer disease in children. Am J Dis Child. 1988;142:1149-1152.
23. Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 1988;2:1437-1442.
24. Oderda G, Farina L, Ansaldi N. Peptic ulcer in children: 5 years follow-up after ranitidine therapy (abstract). Pediatr Res. 1988;24:417.
25. Burstein M, Monge E, Leon-Barua R, et al. Low peptic ulcer and high gastric cancer prevalence in a developing country with a high prevalence of infection by Helicobacter pylori. J Clin Gastroenterol. 1991;13:154-156.
26. Oderda G, Vaira D, Holton J. Seroconversion for Helicobacter pylori (letter). J Clin Pathol. 1994;47:286.
27. Kuipers EJ, Penna AS, van Camp G, et al. Seroconversion for Helicobacter pylori. Lancet. 1993;342:328-331.
28. Mendall MA, Goggin PM, Molineaux N, et al. Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 1992;1:896-897.
29. Hussel T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet. 1993; 342:571-574.
30. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991;338:1175-1176.
31. Ashorn P, Lāhde PL, Ruuska T, Mäkipernaa A. Gastric lymphoma in an 11-year-old boy: a case report. Med Pediatr Oncol. 1994;22:66-67.
32. Horstmann M, Erttmann R, Winkler K. Relapse of MALT lymphoma associated with Helicobacter pylori after antibiotic treatment. Lancet. 1994; 343:1098-1099.
33. Blecker U, Blecker U, McKeithan TW, et al. Resolution of Helicobacter ptlori-associated gastric lymphoproliferative disease in a child Gastroenterology. 1995;109:973-977.
34. De Giacomo C, Lisato L, Negrini R, et al. Serum immune response to Heli-cobacter pylori in children: epidemiologic and clinical applications. J Pediatr. 1991;199:205-210.
35. Oderda G, Vaira D, Holton J. Age-related increase of Helicobacter pylori prevalence in symptom-free and in dyspeptic children. Lancet. 1992; 340:671-672.
36. Thomas JE, Whatmore AM, Barer MR, el al. Serodiagnosis of Helicobacter pylori infection in childhood. J Clin Microbiol. 1990;28:2641-2646.
37. Holcombe C, Tsimiri S, Elridge J, Jones DM. Prevalence of antibody to Helicobacter pylori in children in northern Nigeria. Trans R. Soc Trop Med Hyg. 1993;87:19-21.
38. Sullivan PB, Thomas JE, Wight DGD, et al. Helicobacter pylori in Gambian children with chronic diarrhea and malnutrition. Arch Dis Child. 1990; 65:189-191.
39. Klein PD, Graham DY, Gaillour A, et al. Water source as a risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group. Lancet. 1991; 337:1503-1506.
40. Hazell SL, Mitchell HM, Hu PJ, et al. Gastric cancer: is childhood acquisition of Helicobacter pylori the key (abstract)? Ir J Med Sci. 1992;161(Suppl. 10):22.
41. Blecker U, Lanciers S, Hauser B, Vandenplas Y. The prevalence of Helicobacter pylori in a symptom-free population, aged 1 to 40 years. J Clin Epidemiol. 1994;47:1095-1098.
42. Fiedorek SC, Malaty HM, Evans DL, et al. Factors influencing the epidemiology of Helicobacter pylori infection in children. Pediatrics. 1991;88:578-582.
43. Banatvala N, Mayo K, Mégraud F, et al. The cohort effect and Helicobacter pylori. J Infect Dis. 1993;168.219-221.
44. Parsonnet J, Blaser MJ, Perez-Perez GI, et al. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology. 1992;102:41-46.
45. Veldhuyzen van Zanten SJO, Pollak PT, Best LM, et al. Increasing prevalence of Helicobacter pylori infection with age: continuous risk of infection in adults rather than cohort effect. J Infect Dis. 1994;169:434-437.
46. Mégraud F. Epidemiology of Helicobacter pylori infection. Gastroenterol Clin North Am. 1993;1:73-88.
47. Blecker U, Lanciers S, Hauser B. Validation of a new serologic test for the detection of Helicobacter pylori. Acta Gastroenterol Belg. 1993;56:309-314.
48. Blecker U, Lanciers S, Hauser B, Suys B, et al. Positive and negative titres of a new serologic test for the detection of Helicobacter pylori. Eur J Gastroenterol Hepatol. 1993;5:631-634.
49. Dooley CP, Cohen H, Fitzgibbons PL, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med. 1989;321:1562-1566.
50. Gregson DB, Low DE, Cohen MM, et al. The prevalence of Campylobacter pylori gastritis among asymptomatic adults. Can Med Assoc J. 1989;140:1449-1453.
51. Blecker U, Vandenplas Y. Ethnic differences in Helicobacter pylori infection (letter) Eur J Pediatr. 1993;152:377-378.
52. Rotter JI, Sones JQ, Samloff IM, et al. Duodenal ulcer disease associated with elevated serum pepsinogen I: an inherited autosomal dominant disorder. N Engl J Med. 1979;300:63-66.
53. Asaka M, Kimura T, Kudo M, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992;102:760-766.
54. Graham DY, Go MF. Helicobacter pylori: current status. Gastroenterology. 1993;105:279-282.
55. Blecker LT, Lanciers S, Hauser B, et al. The contribution of specific IgM antibodies to the diagnosis of Helicobacter pylori infection in children. Eur J Gastroenterol Hepatol. 1995;7:979-983.
56. Tytgat GNJ, Noach LA, Rauws EAJ. Helicobacter pylori infection and duodenal ulcer disease. Gastroenterol Clin North Am. 1993;22:127-139
57. Graham DY. Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J Gastroenterol Hepatol. 1991;6:105-113.
58. Figura N, Gugliemeti P, Rossolini A, et al. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol. 1989;27:225-226.
59. Blecker U, Lanciers S, Mehta DI, Vandenplas Y. Familial clustering of Helicobacter pylori infection. Clin Pediatr. 1994;33:307-308.
60. Yoshimura HH, Evans DG, Graham DY. DNA-DNA hybridization demonstrates apparent genetic differences between Helicobacter pylori from patients with duodenal ulcer and asymptomatic gastritis. Dig Dis Sci. 1993; 38:1128-1131.
61. Covaccio A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U.S.A. 1993;90:5791-5795.
62. Graham DY, Malaty HM, GO MF. Are there susceptible hosts to Helicobacter pylori infection? Scand J Gastroenterol. 1994;29(Suppl 205):6-10.
63. Whitaker CJ, Dubiel AJ, Galpin OP. Social and geographical risk factors in Helicobacter pylori infection. Epidemiol Infect. 1993;111:63-70.
64. Webb PM, Knight T, Greaves S, et al. Relation between infection with Helicobacter pylori and living conditions in childhood: evidence for person to person transmission in early life. Br Med J. 1994;308:750-753.
65. Malaty HM, Graham DY. Importance of childhood and socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut. 1994; 35:742-745.
66. Glassman MS, Schwarz SM, Medow MS, et al Campylobacter pylori-related gastrointestinal disease in children. Incidence and clinical findings. Dig Dis Sci. 1989;34:1501-1504.
67. Blecker U, Lanciers S, Vandenplas Y. The role of Helicobacter pylori in children with recurrent abdominal pain: the Brussels experience. Int Pediatr. 1994;9:276-279.
68. Cadranel S, Goossens H, DeBoeck M, et al. Campylobacter pyloridis in children (letter). Lancet. 1986;1:735-736.
69. Mahony MJ, Wyatt JI, Littlewood JM. Campylobacter pylori gastritis. Arch Dis Child. 1988;63:654-655.
70. Czinn SJ, Carr HS. Rapid diagnosis of Campylobacter pyloridis associated gastritis. J Pediatr. 1987;110:569-570.
71. Veereman-Wauters G, Ferrell L, Heyman MB. Trends in Campylobacter pylori in pediatric and adult antral biopsies. A 5-year retrospective analysis. Western J Med. 1989;151:406-409.
72. Mahony MJ, Wyatt JI, Littlewood JM. Campylobacter pylori gastritis. Arch Dis Child. 1988;63:654-655.
73. Crabtee JE, Mahony MJ, Taylor JD, et al. Immune responses to Helicobacter pylori in children with recurrent abdominal pain. J Clin Pathol. 1991; 44:768-771.
74. Prieto G, Polanco I, Larrauri J, et al. Helicobacter pylori infection in children: clinical, endoscopic, and histologic correlations. J Pediatr Gastroenterol Nutr. 1992;14:420-425.
75. Kosunen TU, Höök J, Rautelin HI, Myllylä G. Age-dependent increase of Campylobacter pylori antibodies in blood donors. Scand J Gastroenterol. 1989;24:110-114.
76. Montgomery E, Martin DF, Peura DA. Rapid diagnosis of Campylobacter pylori by Gram's stain. Am J Clin Pathol. 1988;90:606-609.
77. Blecker U, Lanciers S, Hauser B, Vandenplas Y. Diagnosis of Helicobacter pylori infection in adults and children by using the Malakit Helicobacter pylori, a commercially available enzyme-linked immunosorbent assay. J Clin Microbiol. 1993;31:1770-1773.
78. Blecker U, Lanciers S, Hauser B, et al. Serology as a valid screening test for Helicobacter-pylori infection in asymptomatic subjects. Arch Pathol Lab Med. 1995;119:30-32.
79. 13C-urea breath test to the detection of Helicobacter pylori gastritis in children. Pediatrics. 1992;90:608-611.
80. Martin DF, Hollanders D, May SJ, et at. Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet. 1981;1:7-10.
81. Graham DV, Klein PD, Opekun AR, et al. In vivo susceptibility of Campylobacter pylori. Am J Gastroenterol. 1989; 84:233-238.
82. Unge P, Ekström P. Effects of combination therapy with omeprazole and an antibiotic on Helicobacter pylori and duodenal ulcer disease. Scand J Gastroenterol 1993;28(Suppl. 196):17-18.
83. Borody TJ, Brandl S, Andrews P, et al. Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori. Am J Gastroenterol 1994;89:33-38.
84. Graham DY, Lew GM, Ramirez FC, et al. Short report: a non-metronidazole trriple therapy for eradication of Helicobacter pylori infection - tetracycline, amoxicillin, bismuth. Alim Pharmacol Therap. 1993;7:111-113.
85. Bazzoli F, Zagari RM, Fossi S, et al. Efficacy and tolerability of a short term, low dose triple therapy for eradication of Helicobacter pylori (abstract). Gastroenterology. 1993;104:A-40.
86. Moayyedi P, Axon ATR. Efficacy of a new one week triple therapy regime in eradicating Helicobacter pylori. Gut. 1994;35(Suppl.):F248.
87. Bazzoli F, Zagari RM, Fossi S, et al. Short-term, low dose triple therapy for eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol. 1994;6:773-777.
88. Labenz J, Stolte M, Rühl GH, et al. One week law dose triple therapy for cure of Helicobacter pylori. Eur J Gastroenterol Hepatol. 1994;7:9-11.
89. Burette A, Glupczynski Y, Deprez C. Helicobacter pylori relapse rate after successful eradication (abstract). Am J Gastroenterol. 1994;89:1365.
90. Axon ATR. Helicobacter pylori therapy: effect on peptic ulcer disease. J Gastroenterol Hepatol. 1991;6:131-137.
91. Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet. 1990;335:1233-1235.
92. Malfertheiner P. Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment. Scand J Gastroenterol 1993;28(Suppl. 196):34-37.
93. Malfertheiner P, Nilius M. Bismuth salts. In: Goodwin CS, Worsley B, eds. Helicobacter pylori: Biology and Clinical Practice. Boca Raton: CRC Press, 1993.
94. Tucci A, Corinaldesi R, Stanghellini V, et al. One-day therapy for treatment of Helicobacter pylori infection. Dig Dis Sci. 1993;38:1670-1673.
95. Labenz J, Ruhl GH, Bertrams J, Borsch G. Medium- or high dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease. Am J Gastroenterol. 1994; 89:726-730.
96. Logan RP, Gummett PA, Schaufelberger HD, et al. Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut. 1994;35: 323-326.
97. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology. 1992;102:493-496.